Biopartners, INC.:1270141 [18-066447]

Ended Awarded Sep 17, 2018 Last action Jun 8, 2023

Contract number: 75N91018F00003
Awardee: Biopartners, Inc. UEI LKRBK3CCNNN9
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $28,560

Award facts

Opportunity: N02CO5441602 Solicitation number

Full and Open Competition Tissue Purchase Order Acquisitions for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) Award Notice · Posted Jul 30, 2015
Contract value 100% obligated: $28,560.00 Current and potential, with all options
Completion date 100% complete: Sep 16, 2020 Current and potential, with all options
NAICS code: 325413 In-Vitro Diagnostic Substance Manufacturing
PSC: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside: No set-aside
Competition: Competed under SAP · 1 offer Multiple Award, Fair Opportunity
Pricing: Firm Fixed Price
Place of performance: Woodland Hills, CA 91367, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Supplemental Agreement for work within scope P00004	-$116,280	Jun 8, 2023
Other Administrative Action P00003 · Tissue source site (TSS) for clinical proteomics tumor analysis consortium (CPTAC) imaging	$0	Nov 8, 2019
Exercise an Option P00002 · For option period 1: exercise option period 1; and 2) fund 3 additional cases; for optional quantity 1 within exercise option period 1; and 2) fund 77…	$81,600	Aug 26, 2019
Other Administrative Action P00001	$0	Apr 1, 2019
Original award	$63,240	Sep 14, 2018

75N91018F00003 was awarded to Biopartners, Inc. by National Cancer Institute (National Institutes of Health) on September 17, 2018.

The government has obligated $28,560 on 75N91018F00003.

Yes. 75N91018F00003 is a delivery order under HHSN261201600012I, an indefinite delivery contract, on Tissue Source Site for Tumor Analysis.

The extent of competition for 75N91018F00003 was competed under sap. The government received 1 offer.

On GovTribe

Try for free Login